Claimed effect · Carnosine

Does Carnosine help with blood glucosein prediabetes and type 2 diabetes?

C
Grade C — weak human evidence8 RCTs (n=377) pooled · effect size: small
Short answerWeak human evidence. 8 RCTs (n=377) pooled: enough to be interesting, not enough to count on. Where an effect is seen it is a small effect. Standardised mean differences of about half a standard deviation for fasting glucose and a third for HbA1c against placebo. Trials of 12–14 weeks; several at high risk of bias.

What the studies show

Standardised mean differences of about half a standard deviation for fasting glucose and a third for HbA1c against placebo. Trials of 12–14 weeks; several at high risk of bias.

“Our analysis indicated that supplementation significantly reduced fasting blood glucose (FBG) (SMD: -0.53; 95% CI: -0.75 to -0.31; p < 0.00001) and hemoglobin A1c (HbA1c) levels (SMD:-0.36; 95% CI:-0.59 to -0.12; p = 0.003) compared to placebo.”

Verbatim, from the abstractLi N, et al. Effect of carnosine or beta-alanine supplementation therapy for prediabetes or type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. BMC Endocr Disord, 2025

A few small or poorly-controlled human studies. Enough to be interesting; not enough to count on. Most of what gets called “clinically proven” online lives here.

  1. 1

In context

Carnosine is a dipeptide of beta-alanine and histidine concentrated in muscle and brain, sold as a supplement for glucose control, ageing and exercise. A 2025 meta-analysis of eight randomised trials in 377 people with prediabetes or type 2 diabetes found modest reductions in fasting glucose and HbA1c against placebo, with no effect on weight or insulin resistance. The trials are small and short, and oral carnosine is largely broken down in blood before it reaches tissue. It is a food supplement, not a medicine.

Carnosine is food supplement. Legal status differs by country — see the regulation section or the jurisdiction pages.

Questions

Is Carnosine proven to help with blood glucosein prediabetes and type 2 diabetes?
No. The human evidence is weak (8 RCTs (n=377) pooled); LYO grades it C.
What studies are behind the grade?
Standardised mean differences of about half a standard deviation for fasting glucose and a third for HbA1c against placebo. Trials of 12–14 weeks; several at high risk of bias.
Is Carnosine approved for this?
No. Carnosine is food supplement; it is not an approved medicine for any indication in the jurisdictions LYO covers.

Other outcomes for Carnosine

Written and maintained by LYO Research — how pages are written and checked. Reviewed 23 September 2026. Grades count human evidence only; see how LYO grades. Not medical advice. Correct this page →